ScholarGate
アシスタント

手法を比較

選択した手法を並べて確認できます。異なる行はハイライト表示されます。

線維筋痛症インパクト質問票×EORTC QLQ-C30×
分野健康アウトカム健康アウトカム
系統Process / pipelineProcess / pipeline
提唱年19911993
提唱者Cynthia S. Burckhardt et al.Nico Aaronson et al.
種類Self-report symptom and functional impairment questionnaireSelf-report quality of life questionnaire
原典Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735. link ↗Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗
別名FIQ, Fibromyalgia Impact, Fibromyalgia QuestionnaireQLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
関連45
概要The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.
ScholarGateデータセット
  1. v1
  2. 3 出典
  3. PUBLISHED
  1. v1
  2. 3 出典
  3. PUBLISHED

検索へ スライドをダウンロード

ScholarGate手法を比較: FIQ · EORTC QLQ-C30. 2026-06-19に以下より取得 https://scholargate.app/ja/compare